In his address at G20 too, Modi had said that India is ready to produce over 5 billion Covid vaccine doses by the end of next year to help the world in its fight against the pandemic.
He had said it was necessary that the World Heatlh Organisation (WHO) approves Indian vaccines at the earliest.
The emergency use listing (EUL) of Bharat Biotech’s Covaxin with the UN agency was pending for almost 90-100 days after the company submitted its expression of interest to WHO in April and started rolling submission of data since July.
Despite over 12 crore doses of Covaxin administered in the country, even those inoculated with two doses of the jab were unable to travel abroad in the absence of the WHO’s recognition of the vaccine.
The technical advisory group, which gives licence to a vaccine for its emergency use listing (EUL), had asked Bharat Biotech on October 26 for additional data to conduct a final risk-benefit assessment before approving the Covid-19 jab for EUL.
WHO maintained that its process for assessing Covid vaccines for emergency use listing is “rigorous, scientific and standardised”.
It involves outside experts on a technical advisory group which reviews data from manufacturers and others to ensure efficacy and safety, it said.
Covaxin has demonstrated 77.8% effectiveness against symptomatic Covid-19 and 65.2% protection against the new Delta variant.
**If you have any Query Related This Post then here is the Source Link**